文献
J-GLOBAL ID:201702285985476211
整理番号:17A1492840
標準治療(C TASK FORCE)に抵抗性の転移性結腸直腸癌患者に対するTAS-102プラスベバシズマブ:研究者主導,非盲検,単一群,多施設,1/2相研究【Powered by NICT】
TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study
著者 (15件):
Kuboki Yasutoshi
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Nishina Tomohiro
(National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan)
,
Shinozaki Eiji
(The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Yamazaki Kentaro
(Shizuoka Cancer Center, Shizuoka, Japan)
,
Shitara Kohei
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Okamoto Wataru
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Kajiwara Takeshi
(National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan)
,
Matsumoto Toshihiko
(National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan)
,
Tsushima Takahiro
(Shizuoka Cancer Center, Shizuoka, Japan)
,
Mochizuki Nobuo
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Nomura Shogo
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Doi Toshihiko
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Sato Akihiro
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Ohtsu Atsushi
(National Cancer Center Hospital East, Kashiwa, Japan)
,
Yoshino Takayuki
(National Cancer Center Hospital East, Kashiwa, Japan)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
9
ページ:
1172-1181
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)